(120) reported that catalpol could effectively inhibit oxidative stress and inflammation in HFD/STZ-induced DN mice and in a high-glucose–induced podocyte model, and that the mechanism may be related to the AMPK/SIRT1/NF-κB pathway, indicating that catalpol has potential value in the treatment of DN. This evidence concerns the gene SIRT1 and liver dysplastic nodule.